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RESEARCH
Acute skeletal muscle wasting 
and dysfunction predict physical disability 
at hospital discharge in patients with critical 
illness
Kirby P. Mayer1,2* , Melissa L. Thompson Bastin3, Ashley A. Montgomery‑Yates4, Amy M. Pastva5, 
Esther E. Dupont‑Versteegden1,2, Selina M. Parry6† and Peter E. Morris4†
Abstract 
Background: Patients surviving critical illness develop muscle weakness and impairments in physical function; how‑
ever, the relationship between early skeletal muscle alterations and physical function at hospital discharge remains 
unclear. The primary purpose of this study was to determine whether changes in muscle size, strength and power 
assessed in the intensive care unit (ICU) predict physical function at hospital discharge.
Methods: Study design is a single‑center, prospective, observational study in patients admitted to the medicine or 
cardiothoracic ICU with diagnosis of sepsis or acute respiratory failure. Rectus femoris (RF) and tibialis anterior (TA) 
muscle ultrasound images were obtained day one of ICU admission, repeated serially and assessed for muscle cross‑
sectional area (CSA), layer thickness (mT) and echointensity (EI). Muscle strength, as measured by Medical Research 
Council‑sum score, and muscle power (lower‑extremity leg press) were assessed prior to ICU discharge. Physical func‑
tion was assessed with performance on 5‑times sit‑to‑stand (5STS) at hospital discharge.
Results: Forty‑one patients with median age of 61 years (IQR 55–68), 56% male and sequential organ failure assess‑
ment score of 8.1 ± 4.8 were enrolled. RF muscle CSA decreased significantly a median percent change of 18.5% from 
day 1 to 7 (F = 26.6, p = 0.0253). RF EI increased at a mean percent change of 10.5 ± 21% in the first 7 days (F = 3.28, 
p = 0.081). At hospital discharge 25.7% of patients (9/35) met criteria for ICU‑acquired weakness. Change in RF EI in 
first 7 days of ICU admission and muscle power measured prior to ICU were strong predictors of ICU‑AW at hospital 
discharge (AUC = 0.912). Muscle power at ICU discharge, age and ICU length of stay were predictive of performance 
on 5STS at hospital discharge.
Conclusion: ICU‑assessed muscle alterations, specifically RF EI and muscle power, are predictors of diagnosis of ICU‑
AW and physical function assessed by 5x‑STS at hospital discharge in patients surviving critical illness.
Keywords: Critical illness, Muscle wasting, ICU‑acquired weakness, Physical function, Acute respiratory failure, Sepsis, 
Muscle atrophy, Muscle power
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Background
Patients surviving critical illness have significant skeletal 
muscle wasting and dysfunction, including weakness and 
atrophy [1, 2]. Up to two-thirds of patients admitted for 
critical illness will be diagnosed with intensive care unit-
acquired weakness (ICU-AW) [3], leading to deficits in 
Open Access
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physical function [4, 5]. As a result, survivors have long-
term physical disability leading to difficulty performing 
activities of daily living (ADL), such as standing up from 
a chair, and deficits in these basic ADLs are highly asso-
ciated with poor health related-quality of life (HRQoL) 
[6, 7]. Observational and single-center randomized con-
trolled trials demonstrate that physical rehabilitation 
provided in the ICU may positively influence short- and 
long-term patient outcomes, including greater muscle 
strength at ICU discharge, reduced mechanical ventila-
tion duration and improved HRQoL [8–11]. Moreover, 
clinical practice guidelines recommend physical rehabili-
tation for mitigating the detrimental effects of immobili-
zation that occur during critical illness [12, 13]. However, 
recent ICU-based physical rehabilitation randomized 
controlled trials (RCTs) fail to demonstrate robust imme-
diate or long-term functional benefits [11, 14–18]. One 
potential explanation for these results is subject hetero-
geneity [19]. Also, rehabilitation trials rarely implement 
or stratify interventions based on muscular dysfunction 
leading to “one-size fits-all” interventions.
Muscle strength and muscle power are vital compo-
nents of muscular function. Muscle power is differenti-
ated from muscle strength in that power accounts for 
velocity (distance/time) of force production, while mus-
cle strength is the ability to generate maximal muscle 
force only [20]. Muscle power is crucial for daily activi-
ties that require velocity to overcome distance or gravity, 
such as standing up from a chair or from a toilet [21, 22]. 
However, muscle power is not a current focus in ICU or 
hospital rehabilitation. Assessment of muscle power is 
novel in this population, and deficits in power suffered 
during critical illness may help explain persistence of 
physical function impairments.
Early classification of muscle wasting and dysfunction, 
including the degree of deficit, is important for appropri-
ate allocation of rehabilitation interventions, but difficult 
due to the heterogeneity and severity of acute critical 
illness [23]. Muscle ultrasound has gained significant 
traction as a tool to assess and track changes in skeletal 
muscle potentially improving classification of patients 
who may be at risk for muscular or physical impairments. 
However, data surrounding muscle ultrasound are con-
flicting. A recent study demonstrated that muscle size 
measured at day 7 of ICU admission was not predictive 
of ICU-AW [24], while an observational study in a cohort 
of 22 critically ill patients demonstrated that muscle size 
and quality were associated with physical function at ICU 
discharge [25]. Additionally, earlier and greater change 
in muscle size measured by ultrasound was associated 
with in-hospital mortality, mechanical ventilation (MV) 
duration and ICU-AW [26]. Conflicting evidence may 
be attributed to the heterogeneity in patient populations 
and potentially discrepancies in user approach leading 
to variations in practice and human operator error [27]. 
Currently, there is a need to determine whether muscle 
mass, quality and function assessed in ICU are related to 
or predictive ICU-AW and physical function at hospital 
discharge. The purpose of this study was to determine 
whether muscle alterations assessed during an ICU stay 
by changes in muscle size, quality, strength and power, 
are associated with or predict diagnosis of ICU-AW and 
physical function at hospital discharge.
Methods
Ethical considerations
This study was reported in accordance with the Strength-
ening the Reporting of Observational Studies in Epi-
demiology (STROBE) guidelines and approved by the 
Institutional Review Board at the University of Kentucky. 
Research subjects or legally authorized representative 
provided written informed consent before participating 
in the study. Consent was obtained from a legally author-
ized representative for patients unable to give consent 
due to sedation, mentation and/or consciousness, and re-
consent was obtained once patient was awake, stable and 
could provide informed consent themselves.
Study design
A prospective, longitudinal observational study was con-
ducted with adult patients admitted to Medicine ICU 
(MICU) or the Cardiothoracic ICU (CTICU) and enroll-
ment occurred from November 15, 2018, to July 15, 2019. 
Eligibility criteria were: 18  years of age or older with a 
primary or secondary diagnosis of acute respiratory fail-
ure (ARF) or sepsis of any origin that were anticipated to 
spend more than 3  days in the MICU/CTICU and sur-
vive the current hospitalization and enrolled within 48 h 
of admission. In 2019, patients admitted to MICU had 
a variety of admitting diagnoses with a mean sequential 
organ failure assessment (SOFA) of 6.3 with mean ICU 
length of stay (LOS) of 4.9  days and all-cause mortality 
of 21% [28]. Patients in the CTICU have a similar acuity 
level requiring critical care for postoperative cardiac and 
thoracic surgery, as well as patients requiring extra-cor-
poreal membrane oxygenation for any indication. Thus, 
the inclusion criterion with diagnosis of ARF and sepsis 
was utilized to set a minimum severity level to reduce 
the heterogeneity given the MICU and CTICU have a 
diverse patient population with range of severity of ill-
ness. Patients were excluded from enrollment if they had 
baseline cognitive impairments, were non-ambulatory 
prior to hospitalization, had a pre-existing neurologic 
or neuromuscular disorder, new traumatic injury with 
lower-extremity fracture, one or more amputations of 
lower-extremity, were pregnant, admitted for substance 
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abuse or were otherwise inappropriate for study proce-
dures as determined by the primary attending physi-
cian. Patients with morbid obesity (body mass index 




The right quadriceps femoris muscle and the right tibialis 
anterior (TA) were assessed for muscle size and echoin-
tensity (EI) with the SonoSite IViz (FUJIFILM SonoSite 
Inc. Bothell, WA) portable ultrasound with 8.5-MHz 
linear transducer on ICU days 1, 3, 5 and 7. Ultrasound 
device settings were kept constant for subjects across 
time points with the same sonographer (KM, physical 
therapist, PhD, > 4 years of muscle ultrasound experience) 
acquiring all images [29]. The methods for image acquisi-
tion and analysis of quadriceps and TA were previously 
reported [1, 30] and have good to excellent reliability [29, 
31–33]. Minimal probe compression and depth of 5.9 cm 
were utilized to obtain three images at all time points 
of both muscles. Quadriceps femoris muscle imaged at 
2/3 distance from anterior superior iliac spine (ASIS) 
to superior patella border and TA muscle imaged at 1/3 
distance from lateral tibial plateau to inferior border of 
the lateral malleolus. Images were saved on the device 
hard drive and transferred to computer for analysis using 
ImageJ software (NIH, Bethesda, MD). The average value 
of three consecutive images was used in analyses [25, 27]. 
Quadriceps femoris ultrasound images were analyzed 
for quantification of rectus femoris (RF) muscle cross-
sectional area (CSA), RF muscle thickness (mT), quadri-
ceps complex (QC) muscle thickness (rectus femoris plus 
vastus intermedius thickness) and for muscle quality (EI) 
[29]. TA muscle ultrasound images were analyzed for mT, 
CSA and EI. The final analyses included two approaches: 
CSA, mT and EI on ICU day one of admission to ICU 
(baseline) and parameters as percentage change from 
ICU day 1 to day 7.
Prior to volitional assessments, the patient had to 
be oriented (determined as ability to complete 3 of 4 
domains of name, birthday, location and date) and follow 
simple commands by scoring ≥ 3/5 on DeJonghe criteria 
[34].
Muscular strength, power and physical function
Muscle strength was assessed using three different tech-
niques at ICU discharge and hospital discharge:
1 The Medical Research Council-sum score (MRC-
ss) is a measure of global peripheral limb muscle 
strength that is standard of care for diagnosing ICU-
AW with less than 48/60 denoting diagnosis [34–37].
2 Muscle strength force production and the rate of 
force development of the right knee extensors and 
right ankle dorsiflexors were recorded using a hand-
held dynamometry (HHD) (Lafayette Manual Mus-
cle Test System Model-01165, Lafayette Company, 
Lafayette, IN) [38]. HHD to assess isometric mus-
cle strength is reliable and correlated with the gold 
standard of isokinetic dynamometry [38]. Knee 
extension was measured in supine or semi-reclined 
(head of bed < 30 degrees) position with 20 degrees 
of knee flexion using a roll with dynamometer posi-
tioned proximal to the foot on the tibia [39]. Ankle 
dorsiflexion was measured with the knee in ~ 5 
degrees of flexion (small towel under the knee) and 
supported on a hospital bed or leg rest with the ankle 
in neutral with dynamometer positioned on the dor-
sum of the mid-foot. Patients unable to extend lower 
limb or dorsiflexion foot against gravity (< 3/5 on 
MRC-ss for knee extension and ankle dorsiflexion) 
did not perform HHD. Patients participated in a min-
imum one practice repetition with therapist provid-
ing standardized verbal cues for activation, direction 
and encouragement. The peak value of six second 
contraction was recorded, and the average of three 
repetitions was used in analyses with patients resting 
a minimum of 30 s between repetitions.
3 Handgrip strength of dominant hand was assessed at 
ICU discharge and hospital discharge using the Jamar 
hydraulic dynamometer (Sammons Preston Rolyan, 
Bolingbrook, IL, USA) with technique, position and 
cues previously described [37, 40]. The average of the 
peak values for three repetitions was utilized in the 
analysis.
Muscle power was assessed at or prior to  ICU dis-
charge and again at hospital discharge with a linear 
potentiometer (HUMAC-360, CSMi, Stoughton, 
MA) to record the velocity and peak-velocity of a 
unilateral lower-extremity press using a Shuttle Mini-
Press (Shuttle Systems, Bellingham, WA) while sit-
ting in hospital bed or seated in hospital chair [41]. 
Subjects performed three repetitions of the leg press 
at two pre-determined levels of resistance, 2 lbs and 
10% of bodyweight. Patients were permitted to per-
form three repetitions for familiarization prior to for-
mal testing.
Physical functional outcomes The primary physi-
cal function outcome of interest was performance 
of 5-times sit-to-stand test (5 × STS) at hospital 
discharge since it is a fundamental component of 
mobility and an independent measure of muscle 
strength and power [42]. The short performance 
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physical battery (SPPB) [43, 44], six-minute walk 
distance (6MWD) [45, 46] and clinical frailty scale 
(CFS) were assessed at hospital discharge. The CFS 
is validated tool assessing frailty based on mobility 
status, cognitive and physical function, and levels of 
independence [47].
Standard rehabilitation and nutrition care Patients 
admitted to MICU/CTICU receive physical therapy 
and occupational therapy as standard of care initi-
ated by order at the discretion of the primary attend-
ing. Physical and occupational therapy sessions 
typically occur 2–5 times per week lasting ~ 30 min 
and initiated upon weaning of sedation with MICU 
and CTICU medical teams attempting to follow the 
ICU Liberation Bundle (A-F) [13]. Patients requir-
ing sedatives and not appropriate for active mobili-
zation receive passive range of motion at minimum 
three times delivered daily by a mobility technician 
or nursing staff. Active mobilization is initiated by 
the interdisciplinary team as soon as sedation is 
weaned and hemodynamic stability is reached per 
prior recommendations [48]. The Physical Func-
tion in the ICU Test (PFIT-s) was performed by staff 
physical therapists according to routine care which 
includes performing the test upon initial evaluation 
in the ICU [49, 50]. Nutritional practice in our insti-
tution aligns with the SCCM/ASPEN guidelines for 
critically ill adults [51]. Our nutrition support ser-
vice assesses all ICU patients and provides an indi-
vidualized enteral nutrition plan within 24 to 48  h 
of ICU admission for patients without volitional 
intake. Enteral and volitional daily nutritional goals 
are based on 25 kilocal/kilogram per day for caloric 
intake (kilocal) and 1.2–2.5  g/kilogram per day of 
protein [51].
Clinical variables Baseline demographics (age, sex, 
BMI), Charlson comorbidity index (CCI) and criti-
cal illness data including ICU admission diagnosis, 
sequential organ failure assessment (SOFA), hours 
of mechanical ventilation (MV), ICU and hospital 
length of stay (LOS), time to first rehabilitation ses-
sion, number of rehabilitation sessions, sedation (yes/
no), use of inotropes and vasopressors (yes/no) and 
mortality (defined as in-hospital mortality plus trans-
fer to inpatient hospice) were assessed.
Statistical considerations
Sample size A priori sample size calculation was not 
performed. The sample size was pragmatically based on 
8-month time frame as well as previously published lit-
erature [1, 25].
Statistical analysis
Data were assessed using descriptive statistics including 
mean and standard deviation (SD) or median and inter-
quartile range (IQR), histograms and Shapiro–Wilk test 
for normality. Ultrasound data were examined for change 
over time using a linear mixed-model approach. The 
relationships between muscle ultrasound parameters, 
muscle power, muscle strength, demographics, clinical 
and physical function data were assessed with Spearman 
Rho tests. A multivariate logistic regression model was 
created to assess the effects of independent variables on 
development of ICU-AW at hospital discharge. Variables 
identified for the model included baseline demographics 
(age, sex, BMI) and other variables that are purported to 
be associated with weakness including muscle size and 
quality, severity of illness, ICU length of stay and mus-
cle power. Stepwise backward regression at the 0.2 level 
was used to minimize overfitting. Power assessment (10% 
BW) at ICU discharge was forced into the model, as this 
is our primary exploratory predictor variable. Using the 
same approach, a multivariate linear regression was used 
to assess the relationship between predictor variables 
with dependent variable of 5-times sit-to-stand perfor-
mance at hospital discharge. The models were tested for 
assumptions of logistic and linear regression as appropri-
ate. Multicollinearity was assessed using variance infla-
tion factor; normality of errors was assessed with the IQR 
test. We assessed model fit with the Hosmer–Lemeshow 
and likelihood ratio tests. Heteroskedasticity of residuals 
was assessed with the Breusch–Pagan/Cook–Weisberg 
test, and standardized robust errors were used to adjust 
for heteroskedasticity in the models as appropriate. All 
other assumptions were met. Data were analyzed and vis-
ualized using GraphPad Prism 8.2 (GraphPad software, 
San Diego, CA), and regression analyses were performed 
using Stata (version 14.2, Stata Corp, College Station, 
Texas, USA).
Results
Forty-eight patients admitted to MICU and CTICU with 
median age of 61 (55–68), 56% (n = 27) males, and admis-
sion SOFA score of 8.1 ± 4.8 was enrolled in this study. 
Seven patients were removed due to missing ultrasound 
images at baseline due to assessor unavailable (n = 1) or 
images available could not be analyzed due to poor qual-
ity (n = 6). Demographic and clinical data of the forty-one 
patients included in the analyses are presented in Table 1. 
The time to first ultrasound measurement was median 
1.1  days (IQR 0.77–1.4) after ICU admission. Paired 
ultrasound data were available for 35 patients on day 
1 and day 7 of ICU admission, and 6 patients had miss-
ing images due to assessor unavailable (n = 2) or patient 
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discharged prior to day 7 (n = 4), and thus, US data from 
ICU day 5 were utilized in analyses. Thirty-five patients 
participated in muscle strength, power and physical func-
tional testing at hospital discharge. One patient’s time 
point was missed by researcher, and 5 patients died or 
transferred to inpatient hospice before discharge (Addi-
tional file 1: Fig. 1).
Muscle ultrasound parameters (n = 41), Fig. 1
mT
Rectus femoris mT at baseline was 0.98 ± 0.3  cm and 
decreased at median percent change of 20.1 (IQR 12 to 
26%) from ICU day 1 to day 7, statistically significant 
change over time (F = 34.89, p = 0.0316). The quadri-
ceps complex mT at baseline was 2.04 ± 0.71  cm and 
decreased at median percent change of 14.5 (IQR 7% to 
24%) in the first seven days (F = 21.7, p = 0.003). Tibialis 
anterior muscle mT was 2.01 ± 0.36  cm at baseline and 
decreased at median percent change of 9.1 (IQR 5% to 
12%) in the first seven days (F = 28.3, p < 0.001).
CSA
RF muscle CSA at baseline was 2.99 ± 0.99  cm2 and 
decreased at median percent change of 18.5% (IQR 11 
to 23%) in the first seven days (F = 26.6, p = 0.0253). TA 
muscle CSA at baseline was 5.3 ± 0.89  cm2 and decreased 
at a median percent change of 8.1 (IQR 5 to 15%) in first 
seven days (F = 34.7, p < 0.001).
EI
Rectus femoris EI at baseline was 91 ± 24.9 and increased 
at a median percent change of 10.5% (IQR − 5 to 20%) in 
Table 1 Patient demographics and critical illness data
IQR = interquartile range; ICU = intensive care unit; BMI = body mass index; SOFA = sequential organ failure assessment; LOS = length of stay; ICU = intensive care unit; 
MV = mechanical ventilation; CRRT = continuous renal replacement therapy; ECMO = extra-corporeal membrane oxygenation;
a MV duration reported in days as median [IQR] for patients (n = 30) that required MV
b CRRT duration reported in days as median [IQR] for patients (n = 5) that required CRRT 
c Duration of sedation reported for patients that received at least one sedative defined as number of days receiving at least one dosage
d Duration of inotrope and pressor for defined as the number of days a patient received at least one dosage
e 2 patients received long-term NMB (8 and 23 days, respectively, in addition 23 patients received a one-time 50 mg doses of rocuronium for intubation or surgical 
procedure) (n = 23, 56%)
Parameter (n = 41)
Age (years), median [IQR] 61 [55–68]
Male, n (%) 23 (56)
BMI (kg/m2), mean (SD) 29.6 (6.3)
Charlson comorbidity index, mean (SD) 5.5 (3.12)
Admitted to medical ICU, n (%) 30 (73)
Admitted to cardiothoracic ICU, n (%) 11 (27)
SOFA at ICU admission, mean (SD) 8.1 (4.8)
ICU LOS days, median [IQR] 8 [4]
Hospital LOS days, median [IQR] 11.2 [8–19]
MV, n (%) 30 (73)
MV, days, median  [IQR]a 3.4 [1–7.7]
CRRT, n (%) 5 (12)
CRRT, days, median  [IQR]b 9.8 [6.9–10.1]
ECMO, n (%) 2 (5)
Sedation, n (%) 24 (59)
Sedation, days, median  [IQR]c 2 [1–3.25]
Inotropes and pressor, n (%) 25 (61)
Inotropes and pressor, days, median  [IQR]d 4 [2–7]
Neuromuscular blocker, n (%)e 2 (5)
Time to first ultrasound measures, days, median [IQR] 1.1 (0.7–1.4)
Time to initial physical therapy session, days, mean (SD) 2.6 (1.84)
Time to initial occupational therapy session, days, mean (SD) 3.2 (2.71)
Number of rehabilitation visits for entire hospital stay, median, [IQR] 6 [4—9.25]
In‑hospital mortality, n (%) 5 (12)
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the first seven days (F = 3.28, p = 0.081). Tibialis anterior 
EI was 82.7 ± 21.2 at baseline and increased at median 
percent change of 15.4 (IQR 7 to 28%) within the first 
7 days (F = 6.73, p = 0.002).
Muscle power
Twenty-six patients completed muscle power at ICU 
discharge with mean 8.0 ± 2.9 W for 2 lbs resistance and 
44.8 ± 22.6 W for 10% of body weight test (Table 2). Mus-
cle power increased from ICU to hospital discharge at a 
median percent change of 35% (IQR 15–55%) for 2 lbs 
resistance and 27% (IQR 7–48%) for 10% of BW resist-
ance. Muscle power assessment at 2 lbs and 10% of BW 
were highly correlated, and therefore, only muscle power 
at 10% of BW was utilized in statistical analysis (Table 3).
Relationship between muscle size, quality, power and 
strength with physical function at hospital discharge (n = 35)
At ICU discharge 39% (12/31) met diagnosis for ICU-AW 
(Table  2). At hospital discharge the mean MRC-ss was 
52.4 (5.7) with 25.7% (9/35) meeting criteria for ICU-
AW. Handgrip strength was 21.7 ± 10  kg and RF mus-
cle strength measured by HHD was 19.8 ± 6.9  kg with 
3.6 ± 1.1  s to peak force production (Table  2). Patients 
scored an average 5.9 ± 4 on SPPB, with 0.56 ± 0.3  m/s 
gait speed and 18.9 ± 14  s to complete 5-times sit-to-
stand test (Table 2). RF EI on day 1 of ICU admission was 
associated with muscle power (rs = − 0.48, p = 0.005), 
performance on 5 × STS (rs = 0.462, 0.013), ICU-AW 
(rs = 0.337, p = 0.048) and CFS score (0.460, 0.003) at 
hospital discharge (Table 3). Muscle power measured at 
ICU discharge was significantly related to ICU-AW and 
CFS at hospital discharge (Table 3). Muscle power meas-
ured at hospital discharge was also significantly related to 
age, SOFA at ICU admission, RF CSA, RF EI and meas-
ures of strength and function (Table 3).
Prediction modeling
Muscle power measured at ICU discharge, changes in 
rectus femoris CSA and EI from day one to seven, and 
sex predicted diagnosis of ICU-AW by < 48/60 on MRC-
ss at hospital discharge in 25 patients with complete 
data. Muscle power and change in RF EI in first 7  days 
of ICU admission were the strongest predictors of ICU-
AW (Table 4, area under curve = 0.912, Additional file 2: 
Fig. 2). Multivariate linear regression demonstrated that 
muscle power, age and ICU LOS are significant predic-
tors of muscle 5 × STS performance at hospital dis-
charge in 22 patients completing all measures (Table 4). 
Muscle power measured prior to ICU discharge was a 
strong independent predictor of sit-to-stand at hospital 
discharge.
Discussion
The results of this study demonstrate that muscle ultra-
sound parameters, specifically RF EI, and lower extremity 
muscle power measured in the ICU are significant pre-
dictors of physical function at hospital discharge. Assess-
ment of muscle quality by ultrasound and muscle power 
in the early course of critical illness, when combined with 
age and ICU LOS, may improve classification and prog-
nostication of patients in the ICU at risk for weakness 
and physical dysfunction. Identifying the risk of physi-
cal impairments in critically ill patients upon admission 
or within the first few days in the ICU is important to 
improve clinical-decision making for therapeutic inter-
ventions. Timely assessment of skeletal muscle promotes 
an increased understanding of type and severity of mus-
cle alterations, which may improve prognostication and 
lead to a more specific dosage of rehabilitation interven-
tions and/or pharmacologic intervention to mitigate cur-
rent or continued decline. Furthermore, muscle power 
is a novel concept that is rarely assessed in patients with 
Fig. 1 Change in rectus femoris and tibialis anterior muscle size and quality in first seven days of ICU stay. Panel (a) percent change of muscle 
layer thickness; panel (b) percent change of muscle cross‑sectional area. (c) Percent change of echo intensity from day 1 to 7. d = days, RF = rectus 
femoris muscle; QC = quadricep complex muscles; TA = tibialis anterior muscle
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and in those patients that have survived critical illness. 
The findings of this study suggest that muscle power 
should be incorporated in routine practice since power is 
a clinically important determinant of physical function.
Muscle power is not a current focus in critical care 
rehabilitation, but is a key component of functional 
mobility [21] and is important because it accounts for 
velocity (time and distance) to perform a task. Muscle 
power may present a novel therapeutic target with focus 
on an individualized training for patients with deficits. 
In older individuals, muscle power has been shown to 
decline earlier and at a steeper rate than muscle strength 
[52, 53], and therefore power training is a modality pur-
ported to mitigate the effects of sarcopenia [54]. Critical 
illness muscle wasting certainly has different underly-
ing mechanisms of muscle atrophy when compared to 
Table 2 Muscle ultrasound, strength, power and physical function
TA = tibialis anterior muscle; RF = rectus femoris muscle; CSA = cross-sectional area, mT = muscle layer thickness; EI = echointensity; MRC-ss = Medical Research 
Council-sum score; VI = vastus intermedius muscle; HHD = handheld dynamometer; RFD = rate of force development; SPPB = short performance physical battery; 
5 × STS = five-times sit-to-stand test; 6 MWT = six-minute walk test; W = watts; CFS = clinical frailty scale
a Ten patients unable to complete test: 4 patients unable to follow commands/poor cognition; 3 patients had < 3/5 strength; 2 were missed by assessor; and 1 patient 
was unable to maintain oxygen saturations > 10% of baseline with simple movement in bed;
b Three unable to complete: 2 patients with < 3/5 strength and 1 patient unable to complete test: missed by assessor
c Five patients unable to complete: 4 patients unable to follow commands/poor cognition, 1 patient declined due to pain
d Twelve patients unable to complete test: patients reported in footnote b plus 2 patients fatigued after initial testing and physically were unable to perform HHD 
testing
e One patient declined due to pain
f Five patients unable to complete: 2 with < 3/5 strength, 2 deferred to pain/fatigue, 1 patient missed by assessor
g Four patients unable to complete: 2 with < 3/5 strength, 1 deferred to pain/fatigue, 1 patient missed by assessor
h Seventeen patients unable to complete test: patients reported in footnote b plus 7 patients unable to stand for balance or walk 4 m without physical assistance
i Twenty-three patients unable to complete test: patients reported in footnote b plus 13 patients unable to stand from chair in time allotted or without assistance
j Eight patients unable to complete: 2 with < 3/5 strength, 2 deferred to pain/fatigue, 1 patient missed by assessor, 3 patients could not perform without assistance
Muscle parameter Day 1 Day 7
Ultrasound parameters n = 41 n = 41
 TA mT (cm) 2.01 (0.36) 1.82 (0.31)
 TA CSA  (cmPP2PP) 5.28 (0.89) 4.71 (0.95)
 TA EI (0–255) 82.7 (21.2) 96.7 (22.6)
 RF mT (cm) 0.98 (0.3) 0.81 (0.27)
 RF + VI mT (cm) 2.04 (0.71) 1.77 (0.62)
 RF CSA  (cmPP2PP) 2.99 (0.99) 2.47 (0.88)
 RF EI (0–255) 90.7 (24.9) 99.1 (27.6)
ICU discharge Hospital discharge
Muscle power (W) n = 26a n = 33b
 2 lbs 8.0 (2.89) 9.6 (3.5)
 10% bodyweight 44.8 (22.6) 58.7 (30.6)
Muscle strength
 MRC‑ss (0–60) 47.1 (7.3) (n = 31)c 51.4 (5.7) (n = 35)e
 RF HHD force (kg) 16.9 (5.3) (n = 24)d 19.8 (6.9) (n = 31)f
 RF HHD RFD (seconds) 3.8 (1.1) (n = 24)d 3.6 (1.1) (n = 31)f
 TA HHD (kg) 14.5 (5.2) (n = 24)d 15.6 (5.4) (n = 31)f
 TA HHD RFD (seconds) 3.9 (1.2) (n = 24)d 3.7 (1.2) (n = 31)f
 Handgrip (kg) 18.2 (9.1) (n = 26)a 21.7 (10.0) (n = 32)g
Physical function
 SPPB 4.7 (3.9) (n = 26)a 5.9 (4.0) (n = 35)e
 4‑m gait speed (m/s) 0.49 (0.18) (n = 19)h 0.56 (0.27) (n = 31)f
 5 × STS (seconds) 14.8 (5.6) (n = 13)i 18.9 (14.5) (n = 28)j
 Balance 1.96 (1.4) (n = 19)h 2.3 (1.2) (n = 31)f
 6 MWT distance (feet) 265 (182) (n = 26)a 455 (424) (n = 35)e
CFS 6.1 (1.5) (n = 36) 5.3 (1.7) (n = 36)
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mechanisms of age-related muscle mass loss. The con-
cepts of muscle power training, however, may be ben-
eficial in both populations. Additionally, more than 
half of ICU admissions in the USA are older individuals 
(> 65 years of age) [55] and thus suggest muscle power is 
an important construct in muscle and physical dysfunc-
tion for those critically ill. The ability to generate force, 
quickly to overcome gravity to stand from seated position 
Table 3 Correlations between  demographics, clinical data and  muscle parameters measured in  the  ICU with  physical 
function at hospital discharge
Ultrasound images analyzed as baseline (day of ICU admission) and change in TA from day 1 to day 7 (delta). Data are displayed as Spearman Rho tests presented as 
correlation coefficient with p value
* Measured at ICU discharge, “Delta” represents the percentage change in muscle mT, CSA and EI from day 1 to day 7
CCI = Charlson comorbidity index; SOFA = sequential organ failure assessment; MRC-ss = Medical Research Council-sum score; RF = rectus femoris muscle; 
HHD = handheld dynamometry; SPPB = short performance physical battery; 5 × STS = five time sit-to-stand test; 6 MWT = six-minute walk test; mT = muscle layer 
thickness; CSA = cross-sectional; EI = echo-intensity; BW = body weight
Variable Muscle, Physical Function and Frailty assessed at Hospital Discharge, rs (p = 0.05)
Muscle power (10% 
BW)
5 × STS ICU-AW 4-m gait speed 6 MWT CFS
Age − 0.543 (p = 0.001) 0.822 (p < 0.001) 0.269 (p = 0.118) − 0.629 (p < 0.001) − 0.596 (p < 0.001) 0.554 (p < 0.001)
BMI 0.096 (p = 0.597) 0.386 (p = 0.042) − 0.285 (p = 0.097) − 0.355 (p = 0.054) − 0.210 (p = 0.219) 0.093 (p = 0.567)
CCI − 0.006 (p = 0.973) 0.369 (p = 0.053) 0.137 (p = 0.431) − 0.269 (p = 0.151) − 0.359 (p = 0.032) 0.340 (p = 0.032)
SOFA − 0.353 (p = 0.044) − 0.352 (p = 0.07) 0.400 (p = 0.017) 0.262 (p = 0.162) 0.144 (p = 0.401) − 0.219 (p = 0.174)
ICU LOS 0.090 (p = 0.618) − 0.262 (p = 0.178) 0.348 (p = 0.041) 0.324 (p = 0.081) 0.028 (p = 0.872) 0.155 (p = 0.339)
Hospital LOS 0.109 (p = 0.545) − 0.323 (p = 0.094) 0.440 (p = 0.008) 0.433 (p = 0.017) 0.061 (p = 0.722) − 0.026 (p = 0.872)
RF mT (day 1) 0.248 (p = 0.160) − 0.145 (p = 0.461) − 0.308 (p = 0.072) 0.002 (p = 0.993) 0.059 (p = 0.732) − 0.152 (p = 0.349)
Delta RF mT 0.112 (p = 0.534) − 0.178 (p = 0.366) − 0.272 (p = 0.114) − 0.082 (p = 0.667) − 0.079 (p = 0.646) 0.047 (p = 0.775)
RF CSA (day 1) 0.379 (p = 0.029) − 0.230 (p = 0.248) − 0.239 (p = 0.166) 0.131 (p = 0.491) 0.211 (p = 0.217) − 0.239 (p = 0.138)
Delta RF CSA − 0.159 (p = 0.375) 0.123 (p = 0.532) − 0.181 (p = 0.297) − 0.261 (p = 0.163) − 0.105 (p = 0.541) − 0.003 (p = 0.983)
RF EI (day 1) − 0.480 (p = 0.005) 0.462 (p = 0.013) 0.337 (p = 0.048) − 0.324 (p = 0.081) − 0.295 (p = 0.080) 0.460 (p = 0.003)
Delta RF EI 0.150 (p = 0.406) − 0.306 (p = 0.110) − 0.214 (p = 0.218) 0.280 (p = 0.134) 0.190 (p = 0.268) − 0.139 (p = 0.392)
PFIT‑s* 0.670 (p < 0.001) − 0.447 (p = 0.019) − 0.640 (p < 0.001) 0.255 (p = 0.191) 0.648 (p < 0.001) − 0.763 (p < 0.001)
MRC‑ss* 0.333 (p = 0.090) − 0.409 (p = 0.047) − 0.626 (p < 0.001) 0.071 (p = 0.731) 0.429 (p = 0.018) − 0.478 (p = 0.006)
Handgrip* 0.712 (p < 0.001) − 0.416 (p = 0.001) − 0.649 (p < 0.001) 0.167 (p = 0.447) 0.365 (p = 0.073) − 0.489 (p = 0.011)
RF HHD* 0.837 (p < 0.001) − 0.396 (p = 0.076) − 0.597 (p = 0.003) 0.122(p = 0.589) 0.443 (p = 0.034) − 0.551 (p = 0.005)
Muscle power (10% 
BW)*
0.819 (p < 0.001) − 0.386 (p = 0.076) − 0.541 (p = 0.005) 0.164 (p = 0.456) 0.384 (p = 0.058) − 0.622 (p = 0.001)
Table 4 Multivariate logistic regression predicting ICU-AW at  hospital discharge and  multivariate linear regression 
predicting sit-to-stand performance at hospital discharge
BW = bodyweight; RF = rectus femoris; CSA = cross-sectional area, EI = echo-intensity; ICU = intensive care unit; LOS = length of stay
Model p = 0.003 R2 = 0.51, VIF = 1 Odds ratio SE z P >|z| [95% CI]
Dependent variable: diagnosis of ICU-AW at hospital discharge, n = 25
Power 10% BW in ICU 0.033 0.04 − 2.02 0.044 0.85, 0.99
Change in RF CSA days 1 to 7  < 0.001 0.0001 − 1.33 0.182 8.12e–13, 197.7
Change in RF EI days 1 to 7 4.40 0.0003 − 1.78 0.074 5.76e−12, 3.36
Male 0.53 1.25 1.56 0.787 0.005, 54.3
Model p = 0.04, R2 = 0.55, VIF 1.11 β-coefficient SE t P >|t| [95% CI]
Dependent variable: performance on 5 × STS test at hospital discharge, n = 22
Power 10% BW in ICU − 0.282 0.124 − 2.26 0.036 − 0.543, − 0.020
Age 0.534 0.173 3.09 0.006 0.171, 0.897
ICU LOS − 0.091 0.033 − 2.76 0.013 − 0.161, − 0.0217
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requires lower-extremity muscle power [56]. Previous 
data suggest that older patients and those with longer 
mechanical ventilation will have delayed time to achieve 
independence with sit-to-stand transfer [57]. Thus, 
5 × STS was selected as the primary physical function 
outcome of interest since it has strong construct validity 
with muscle strength and power, an important measure 
of functional mobility [58, 59]. Changes in muscle power 
may be explained by a selective decrease in type-II mus-
cle fibers, which are most important for power produc-
tion. Data from muscle biopsies demonstrate that type-II 
fibers have smaller CSA and potentially decrease at more 
predominant rate than type-I fibers in patients requiring 
mechanical ventilation [60, 61]. Data from muscle power 
assessment in this study had moderate to strong correla-
tions with rectus femoris muscle size, muscle EI, strength 
and physical function. Rectus femoris muscle has a high 
composition of type IIA and IIX muscle fibers [62] which 
supports the relationship between muscle power and rec-
tus femoris muscle size and quality in this study. Muscle 
power increased from ICU to hospital discharge, which 
may suggest time points in the ICU, may be influenced by 
limited voluntary muscle contraction when patients are 
acutely ill. Muscle power measured at hospital discharge 
in this cohort was significantly reduced compared to pre-
viously reported data from healthy, age-matched con-
trols (reductions up to 47%) [41]. Muscle power should 
be explored in future studies to understand long-term 
recovery.
Results of the current study confirm the rapid and sig-
nificant deterioration in skeletal muscle size and quality 
in patients admitted to the ICU for critical illness that 
have been reported in prior published work [1, 25, 63, 
64]. We demonstrated decrease in RF muscle CSA of 19% 
in first week of critical illness, slightly higher than prior 
data ranging from decreases of 12.5% to 17% [1, 25, 65]. 
It should be noted that baseline RF muscle size (mT and 
CSA) was lower when compared to previous studies [25, 
64]. This may be explained by differences in landmarking, 
variability in sonographer compression technique and, 
more likely, differences in study populations. Specifically, 
the inclusion of patients in the cardiothoracic ICU with 
heart or lung failure with potential for chronic wasting 
and frailty may explain part of the differences in baseline 
rectus femoris muscle size. Differences in techniques and 
heterogeneous populations confirm the need to develop 
standardized approaches when performing muscle ultra-
sound in the ICU [27]. EI, a marker of muscle quality 
[66], increased across these same time points by 10.5%, 
which is similar to prior published data (+ 9.6%) [25]. 
These changes are purported to be clinically meaningful 
deteriorations in the muscle structure potentially related 
to myofiber necrosis [66, 67].
Muscle ultrasound is a non-invasive and relatively 
inexpensive tool that can be implemented early dur-
ing critical illness to potentially expedite classification 
of muscle mass and quality. Early diagnosis and classifi-
cation of patients at risk for physical impairments may 
improve outcomes by promoting earlier allocation or 
greater intensity (number of visits) of physical rehabilita-
tion. Current diagnosis of ICU-AW is typically delayed 
until the patient can volitionally engage in the MRC-
ss [35, 68]. Therefore, ultrasound used early in the time 
course of critical illness when patients are not yet able to 
volitionally engage may improve assessment of muscle 
dysfunction. Data from this study demonstrate that dete-
rioration in rectus femoris muscle quality is moderately 
and significantly correlated with ICU-AW, physical func-
tion and clinical frailty scale at hospital discharge. There-
fore, this study provides preliminary data to suggest that 
quantification of muscle quality with ultrasound imaging 
can improve classification of patients at risk for ICU-
AW and physical impairments. The findings may also 
suggest that muscle size may not be the best predictor 
of outcomes, specifically ICU-AW. Muscle mass or size 
has previously been shown not to correlate with muscle 
strength [69, 70], potentially demonstrating that atrophy 
may not be the primary culprit of ICU-AW. These data, 
interpreted with caution, may support that deteriorations 
in muscle quality and muscle power may partially explain 
development of ICU-AW.
The primary limitation of this study is the small sample 
size limiting the strength of correlations and the strength 
of the modeling or prediction analyses. Multivariate 
logistic and linear regression were performed as explora-
tory analyses and should be interpreted with caution due 
to the study being under-powered. The study was not 
powered to conduct group analyses and such we focused 
on the descriptive data and correlations. Additional 
exploratory analyses were not performed in this study 
as the primary aim was focused on early muscle assess-
ment to predict physical function at hospital discharge. A 
secondary limitation is some missing data due to assessor 
availability or the patient unable to complete tests due to 
pain, lack of cognitive function or change in care to hos-
pice or comfort care. Finally, research conducted in the 
ICU is limited due to timing; it is likely that patients have 
suffered changes in muscle and physical function long 
before admission to the ICU which makes establishing a 
baseline nearly impossible.
Conclusion
In this study we showed that changes in muscle quality 
and power assessed in the ICU are significantly related 
to physical function in patients with critical illness. 
Muscle power could be an important clinical measure 
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to be considered in the assessment of patients with and 
those patients that have survived critical illness.
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